Name: Can-Fite BioPharma
Address: 10 Bareket Street, Petah-Tikva, 49170, ISRAEL
Telephone: +972-3-9241114

Filing Type:

Year:

Date	Form	Description	Pages
06/12/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments	3
06/06/19	SC 13D/A	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Documents expand_more EX-24.1	6
06/03/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	7
05/31/19	D	Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.	6
05/30/19	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	9
05/30/19	SC 13D	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities Documents expand_more EX-99.1	8
05/29/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	10
05/28/19	F-1/A	Registration statement for securities of certain foreign private issuers Documents expand_more EX-4.8 EX-5.1 EX-23.1	67
05/24/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments	3
05/23/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	6